Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Small bowel mass
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== '''Epidemiology''' == * Small bowel is responsible for <2% of primary GIT malignant neoplasms ** More dilute and liquid contents of small bowel may cause less mucosal irritation than in the colon ** Rapid transit may reduce contact with carcinogens ** Lower bacterial load may reduce carcinogen exposure ** Increased lymphoid tissue may be protective ** Certain protective enzymes are only present in SB to metabolise carcinogens * High cancer rates among Maori and ethnic Hawaiians, low in Indians and Eastern Europeans * Overall slow increase in incidence in USA - mostly driven by rise in NETs * Mean age at diagnosis of 65yo for SB tumours in general == '''Risk factors''' (for any mass) == * Genetic - FAP, Peutz-Jeghers, HNPCC * Chronic inflammation - coeliac, IBD, CF * Structural - Meckel's * Prior PUD * Previous cholecystectomy * May contribute: ** Dietary - processed sugar, smoked/cured meats/red meat ** Smoking ** Heavy alcohol consumption == Differential diagnosis == === '''Benign lesions''' (see separate topic) === * Approach ** Mostly asymptomatic ** If symptomatic, more likely to present with GIT bleed, not abdo pain ** Consideration of excising includes malignant potential, as well as symptomatology ** Resect when found - probably will become symptomatic in the future * Adenoma * Lipoma * Leiomyoma * Hamartoma * Haemangioma * Desmoid tumour * Lymphangioma * Fibromyxoma * Ganglioneuroma === '''Malignant''' (descending order of prevalence) === * '''NET''' (neuroendocrine tumour) (44%) ** See separate topic * '''Adenocarcinoma''' (33%) ** See separate topic * '''Lymphoma''' (8%) ** See separate topic * '''Mesenchymal tumours (GIST)''' (17%) ** See 'GIST' under 'UGIS' and separate topic in this section ** Also leiomyosarcoma * '''Metastatic disease''' ** Generally the result of severe disease with overwhelmingly poor prognosis *** Exceptions - melanoma and RCC, where significantly improved prognosis can be found after resection ** Palliative bypass can be considered ** Self-expandable metal stents can be placed in those with low performance status ** Gastrostomy/jejunostomy can be considered ** Extraluminal involvement *** Peritoneal carcinomatosis *** Gastric *** Colon *** Ovarian ** Haematogenous spread *** Melanoma (most common - found in >50% of patients with palliative melanoma) *** Colon *** Breast *** Kidney *** Lung *** Sarcoma == '''Presentation''' == * '''Can't reliably differentiate between benign and malignant based on clinical presentation alone''' * Malignant neoplasms account for 75% of symptomatic lesions that lead to surgery * Majority of symptomatic lesions are malignant ** 94% of malignant lesions were symptomatic in one series, vs 53% of benign tumours ** Malignant lesions present with abdominal pain more commonly than bleed - bleeding is more commonly related to benign tumours * Most benign lesions are asymptomatic * Often vague ** Pain (44-90%) *** (most often related to partial obstruction), ** Nausea/vomiting (17-64%) ** Weight loss (24-44%) - mostly associated with malignant tumours ** GIT bleeding (23-41%) * Obstruction is usually secondary to intussusception ** Benign small tumours are the most common cause of this in adults * Estimated that 10% of occult GI bleeds are secondary to small bowel tumours, but life-threatening haemorrhage is uncommon == '''DDx''' == * Adhesions * Hernia entrapment * IBD * Endometriosis * Splenosis * Complications from appendicitis or diverticulitis == '''Location''' == * Malignant tumour proportion based on location: == '''Diagnosis''' == * Only 50% of symptomatic patients have the correct pre-op diagnosis * Upper GIT series with small bowel follow-through ** Specificity 53-83% for malignant neoplasms * CT abdo/pelvis ** Good for GIST ** Useful for staging * CT enteroclysis ** Diagnostic accuracy of 95% * MRI enteroclysis ** Sensitivity 98%, specificity 97% * Double-balloon enteroscopy ** Reserved for cases which require a tattoo * Capsule endoscopy ** Sensitivity 89-95% and specificity 75-95% for diagnosis of a small bowel tumour in the setting of occult bleeding * FDG PET ** Useful for lesions >1cm * DOTATATE PET ** Useful for suspected NET == '''Workup''' == [[Category:Small bowel]]
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Small bowel mass
Add topic